IgG+ Extracellular Vesicles Measure Therapeutic Response in Advanced Pancreatic Cancer

(1) Background: Pancreatic ductal adenocarcinoma (PDAC) is expected to be the second-leading cause of cancer deaths by 2030. Imaging techniques are the standard for monitoring the therapy response in PDAC, but these techniques have considerable limits, including delayed disease progression detection...

Full description

Bibliographic Details
Main Author: Couto, Nuno (author)
Other Authors: Elzanowska, Julia (author), Maia, Joana (author), Batista, Silvia (author), Pereira, Catarina Esteves (author), Beck, Hans Christian (author), Carvalho, Ana Sofia (author), Moraes, Maria Carolina Strano (author), Carvalho, Carlos (author), Oliveira, Manuela (author), Matthiesen, Rune (author), Costa-Silva, Bruno (author)
Format: article
Language:eng
Published: 2022
Subjects:
pancreatic cancer
extracellular vesicles
liquid biopsy
biomaker
IgG
Online Access:http://hdl.handle.net/10174/33049
http://hdl.handle.net/10174/33049
Country:Portugal
Oai:oai:dspace.uevora.pt:10174/33049

Internet

http://hdl.handle.net/10174/33049
http://hdl.handle.net/10174/33049

Similar Items